Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

46.6K
Overview
46.6K
Conjugated Proteins02:50

Conjugated Proteins

21.2K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
21.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and immunogenicity of mRNA-based mpox vaccine candidate BNT166a: an open-label, dose-escalation, first-in-human trial.

The Lancet. Infectious diseases·2026
Same author

A Study to Investigate the Safety and Immunogenicity of Monovalent Omicron LP.8.1-Adapted BNT162b2 COVID-19 Vaccine in Adults ≥ 65 Years of Age and High-Risk Adults 18-64 Years of Age (Preliminary Results).

Vaccines·2026
Same author

Application of Allometric Scaling and Translational Modeling to Predict Human Pharmacokinetics of mRNA-Encoded Antibodies.

Molecular pharmaceutics·2026
Same author

Strong and early immune responses against SARS-CoV-2 in mice and rhesus macaques after BNT162b3 vaccination.

NPJ vaccines·2026
Same author

T-cell Response Induced by the BNT162b2 COVID-19 Vaccine in Children.

Open forum infectious diseases·2025
Same author

Claudin 6 is a suitable target for CAR T-cell therapy in atypical teratoid/rhabdoid brain tumors and other pediatric solid tumors.

Journal for immunotherapy of cancer·2025

Related Experiment Video

Updated: Oct 19, 2025

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.1K

Racing for a SARS-CoV-2 vaccine.

Özlem Türeci1, Uğur Şahin1,2

  • 1BioNTech SE, Mainz, Germany.

EMBO Molecular Medicine
|September 17, 2021
PubMed
Summary

This interview features EMBO Members Özlem Türeci and Uğur Şahin of BioNTech. They discuss their groundbreaking work in biotechnology and its impact on medical science.

Area of Science:

  • Biotechnology
  • Immunology
  • Medical Science

Background:

  • Özlem Türeci and Uğur Şahin are distinguished EMBO Members.
  • They are key figures at BioNTech, a leading biotechnology company.
  • The interview was conducted by science journalist Kai Kupferschmidt.

Purpose of the Study:

  • To gain insights into the scientific journey and achievements of Türeci and Şahin.
  • To understand the innovations and future directions of BioNTech.
  • To explore the impact of their work on the broader scientific community and public health.

Main Methods:

  • An in-depth interview format was employed.
  • Discussions focused on scientific research, development, and company strategy.
  • Expert commentary from a science journalist provided context.

More Related Videos

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.7K
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

4.9K

Related Experiment Videos

Last Updated: Oct 19, 2025

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.1K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.7K
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

4.9K

Main Results:

  • The interview highlights the pioneering research of Türeci and Şahin.
  • It offers perspectives on the development of novel biotechnological solutions.
  • The discussion touches upon the challenges and successes in their scientific endeavors.

Conclusions:

  • Türeci and Şahin's work at BioNTech represents significant advancements in biotechnology.
  • Their contributions have profound implications for future medical treatments.
  • The interview underscores the importance of scientific leadership and innovation.